Mini Review
Published on 13 May 2026
Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas
Frontiers in Hematology
doi 10.3389/frhem.2026.1812908
- 525 views
191 Publications
volumes
Volume 5 - 2026
Systematic Review
Accepted on 11 May 2026
Reduced-Intensity Versus Intensive Induction in High-Risk Acute Promyelocytic Leukemia: A Systematic Review and Meta-Analysis
Frontiers in Hematology
Review
Published on 11 May 2026
Bridging innovation and equity: the evolving landscape of CAR T-cell therapy access in Brazil
Frontiers in Hematology
doi 10.3389/frhem.2026.1813861
- 588 views
Hypothesis and Theory
Accepted on 06 May 2026
The cells of origin of the chemotherapy curable malignancies are highly sensitive to cytotoxic chemotherapy mediated cell death
Frontiers in Hematology
- 163 views
Original Research
Published on 04 May 2026
Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders
Frontiers in Hematology
doi 10.3389/frhem.2026.1800304
- 644 views
Case Report
Published on 13 Apr 2026
Case Report: Pernicious anemia-associated pancytopenia responds to immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2026.1733719
- 465 views
Original Research
Accepted on 08 Apr 2026
A pilot study on therapeutic drug monitoring of Asparaginase in Indian children with high-Risk ALL: Evidence for Suboptimal Exposure
Frontiers in Hematology
- 446 views
Review
Published on 31 Mar 2026
Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms
Frontiers in Hematology
doi 10.3389/frhem.2026.1749376
- 1,266 views
Case Report
Published on 30 Mar 2026
Case Report: Burkitt’s lymphoma with concurrent HIV, CMV encephalitis, and salmonella bacteremia
Frontiers in Hematology
doi 10.3389/frhem.2026.1727954
- 460 views
Original Research
Published on 30 Mar 2026
Complications and treatment patterns in patients with non-transfusion-dependent α- and β-thalassemia compared with matched controls: a retrospective observational study using administrative claims data in the United States
Frontiers in Hematology
doi 10.3389/frhem.2026.1770034
- 620 views
Editorial
Published on 27 Mar 2026
Editorial: Advances and new horizons in cellular therapies for leukemia and myeloma
Frontiers in Hematology
doi 10.3389/frhem.2026.1812817
- 414 views
Perspective
Published on 26 Mar 2026
Castleman disease mimicking systemic lupus erythematosus: the importance of vigilance in diagnosing autoimmune mimickers
Frontiers in Hematology
doi 10.3389/frhem.2026.1785387
- 542 views
Methods
Published on 18 Mar 2026
Single spectral flow cytometry panel for simultaneous detection of hematopoietic stem, progenitor, and mature lineages in mouse bone marrow
Frontiers in Hematology
doi 10.3389/frhem.2026.1802350
- 1,159 views
Original Research
Published on 16 Mar 2026
Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life
Frontiers in Hematology
doi 10.3389/frhem.2026.1794624
- 922 views
Case Report
Published on 23 Feb 2026
Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center
Frontiers in Hematology
doi 10.3389/frhem.2026.1745884
- 790 views
- 1 citation
Review
Published on 23 Feb 2026
The role of necroptosis as a possible therapeutic target in multiple myeloma: the emerging roles of necroptosis
Frontiers in Hematology
doi 10.3389/frhem.2026.1686097
- 532 views
Case Report
Published on 23 Feb 2026
Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases
Frontiers in Hematology
doi 10.3389/frhem.2026.1776722
- 480 views
Original Research
Published on 12 Feb 2026
Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia
Frontiers in Hematology
doi 10.3389/frhem.2026.1709697
- 859 views
Case Report
Published on 04 Feb 2026
Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia
Frontiers in Hematology
doi 10.3389/frhem.2026.1748301
- 883 views
Original Research
Published on 30 Jan 2026
Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation
Frontiers in Hematology
doi 10.3389/frhem.2026.1733667
- 1,577 views
Editorial
Published on 27 Jan 2026
Editorial: Innovations and challenges in sickle cell disease: bridging gaps in global health
Frontiers in Hematology
doi 10.3389/frhem.2026.1787190
- 1,046 views
Volume 4 - 2025
Case Report
Published on 08 Apr 2026
Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease
Frontiers in Hematology
doi 10.3389/frhem.2025.1650494
- 1,060 views
Case Report
Published on 23 Jan 2026
Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma
Frontiers in Hematology
doi 10.3389/frhem.2025.1683981
- 1,316 views
Case Report
Published on 23 Jan 2026
Daratumumab in severe Evans syndrome: a case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1719208
- 1,370 views